AstraZeneca's Calquence has hit the mark in the phase 3 AMPLIFY trial in chronic lymphocytic leukaemia (CLL), a study that chief executive Pascal Soriot recently said could be a "blockbuster ...
Learn everything you need to know about Amplify Seymour Cannabis ETF (CNBS) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the ...
Learn everything you need to know about Amplify CWP Enhanced Dividend Income ETF (DIVO) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see ...
We are actively working to enhance your experience by translating more content. However, please be aware that the page you are about to visit has not yet been translated. We appreciate your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback